The market is projected to expand at a compound annual growth rate of 6% from 2024 to 2034. Growing clinical evidence is beginning draw attention to the minimally invasive neurosurgical devices market ...
Siemens has announced plans to ‘deconsolidate’ its remaining stake in Siemens Healthineers by transferring 30% of shares to Simens shareholders. The company, whose stake had stood at 67%, will hand ...
Biogen has completed the acquisition of Alcyone Therapeutics, for $85m upfront payment, to boost central nervous system (CNS) drug delivery.
Zimmer Biomet has received 510(k) clearance from the US Food and Drug Administration (FDA) for ROSA Knee with OptimiZe technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback